Horm Metab Res 1980; 12(12): 695-697
DOI: 10.1055/s-2007-999234
© Georg Thieme Verlag, Stuttgart · New York

Effects of Salbutamol and Butoxamine on the Human Fat Cell Adenylate Cyclase

H. Kather, B. Simon
  • Klinisches Institut für Herzinfarktforschung an der Medizinischen Universitätsklinik Heidelberg, Heidelberg, Germany
Weitere Informationen

Publikationsverlauf

1979

1980

Publikationsdatum:
22. April 2008 (online)

Summary

In order to characterize the β-adrenoceptors coupled to the human fat cell adenylate cyclase more extensively the effects of the β2-selective agonist salbutamol on basal and isoproterenol-stimulated rates of cAMP-accumulation were studied. Although exhibiting only low intrinsic activity salbutamol displayed only slightly lower affinity towards the β-adrenoceptors linked to the human fat cell adenylate cyclase than isoproterenol. In addition, the β2-selective antagonist butoxamine was slightly more potent in inhibiting the isoproterenol-stimulated fat cell enzyme than the cardio-selective β-blocking agent practolol. These results further emphasize the difficulties in classifying the lipolytic response of adipose tissue to β-adrenergic agonists and antagonists within a uniform β-receptor theory.

    >